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p3= 0.002). Compared to the preoperatively measured, the fail of the three meas-
ured respiratory functional values on the 7th postoperative day was significantly 
smaller in Group1 than Group2 (VC, FEV1, PEF; Group1: 14.18±12.61%; 12.82±14.31%; 
-6.29±18.46%; Group2: 25.60±16.11%; 23.05±14.93%; 13.70±19.28%; p1= 0.043, p2 = 0.046, 
p3 = 0.004). There was no difference between groups in duration of mechanical ven-
tilation and average stay of intensive care unit. Incidence of atelectasis was 10% in 
Group1, while 0% in Group2. Pre- and postoperative respiratory functional values 
did not correlate significantly with extubation time (p> 0.05). ConClusions: The 
applying of preoperative PT to cardiac surgical patients with COPD is effective since 
the examined respiratory functional values reduced less and increased better in the 
postoperative period at the preoperatively treated group.
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objeCtives: Paediatric advisory committee guidelines recommend palivizumab 
prophylaxis for infants at high risk for respiratory syncytial virus (RSV) infection. 
The objective of this study is to compare the hospitalization rates for respiratory 
illness (RIH) and RSV-positive hospitalizations (RSVH) among infants who received 
palivizumab for various indications. Methods: The Canadian Registry for Synagis 
(CARESS) is a prospective registry of infants who have received ≥ 1 dose of palivizumab 
per RSV season across Canada. Demographic data were collected in 32 Canadian 
national sites during the 2005-2012 RSV seasons. Respiratory illness related hospi-
talization events were recorded monthly. Standard risk indications that qualified for 
RSV prophylaxis were categorized as prematurity (≤ 35 completed weeks gestational 
age), chronic lung disease or bronchopulmonary dysplasia (CLD), hemodynamically 
significant congenital heart disease (CHD), and other serious underlying medical 
disorders (MD). A Cox proportional hazards analysis was conducted to examine differ-
ences in hospitalization rates between the indications. Results: Of the 13,310 infants 
enrolled, 8751 were premature, 1048 had CLD, 1414 had CHD, and 2097 qualified with 
MDs. The overall RIH rate was 6.6% (n= 875) with premature infants having a signifi-
cantly lower rate than the other groups (4.4% vs. 12.2% [CLD], 10.3% [CHD], 10.3% [MD]; 
B= -0.770, df= 1, p< 0.0005). Details of hospitalizations did not differ between groups, 
except the number that were admitted to the Intensive Care Unit which was signifi-
cantly different between groups (χ 2= 11.420, df= 3, p= 0.010). The overall RSVH rate was 
1.55% but was also significantly lower for prematurity (prematurity, 1.36%; CLD, 1.64%; 
CHD, 2.05%; MD, 2.03%; p< 0.0005), with no significant differences between the groups 
in terms of time to RSV hospitalization (χ 2= 1.833, df= 3, p= 0.608). ConClusions: 
RIH and RSVH rates were dissimilar across the groups with premature infants being 
significantly lower compared to the others. However there were no identified group 
differences regarding time to first RSVH.
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objeCtives: To assess the impact of the front loading phone calls counselling on the 
abstinence prevalence at 3 and 6 months after quit date among smokers in Penang, 
Malaysia. Methods: The study was carried out at Quit Smoking Clinic of two major 
hospitals in the state of Penang, Malaysia. All the eligible tobacco users who attended 
the clinics between February 1 and October 31, 2012 were invited. Participants were 
randomly assigned to receive either the usual care (a combination of nicotine gum 
for the first 2 weeks and cognitive behaviour therapy); (control group), or the previous 
combination plus extra counselling sessions through phone calls during the first month 
of quit attempt (intervention group). Results: Two hundred thirty-one subjects were 
recruited during the period under review. The mean age of starting smoking in the 
study population was 17.38 ± 3.9 years. The vast majority of our cohort (96.1%) was 
male. Participants smoked about 14 cigarettes per day on average (mean = 13.78 ± 7.0). 
At 3 months follow-up point, control group was less likely to quit smoking compared 
to intervention group but this did not reach statistical significance (OR = 0.669; 95% CI 
= 0.395-1.133, P = 0.86). However, at 6 months, the abstinence rate significantly differed 
between the standard care and combination of standard care and extra phone calls after 
verification with exhaled carbon monoxide (48.6% vs. 71.7%, respectively: < 0.001). The 
control group were significantly less likely to quit smoking (OR = 0.375; 95% CI = 0.217-
0.645, P< 0.001). ConClusions: Smoking cessation intervention consisting of phone 
calls delivered counselling during the first month of quit attempt results in significantly 
higher abstinence rates compared with a standard care approach. Therefore, the front 
loading counselling is a promising treatment strategy that should be evaluated further.
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objeCtives: Palivizumab is recommended for respiratory syncytial virus (RSV) 
prophylaxis. CARESS tracks palivizumab use and respiratory outcomes in high-risk 
infants, including those with congenital airway anomalies (CAA). Our objective was 
to compare hazards for hospitalization for respiratory illness (RIH) and RSV (RSVH) 
in CAA infants versus those prophylaxed for: 1) other medical disorders (MD) and 2) 
standard indications (SD). Methods: Infants were prospectively recruited from 32 
Canadian sites who received ≥ 1 dose of palivizumab during the 2005-2012 RSV sea-
objeCtives: Modern medicine provides continuous improvement of diagnosis, treat-
ment and prevention methods in accordance with the requirements of best medical 
practice. The system of medical care standardization with regard of the evidence-
based medicine is focused on developing medical and technological documents that 
assist a doctor to act effectively in specific clinical situations, avoiding inefficient and 
false interventions. In view of this, the Ministry of Health of Ukraine has approved 
the methodology for development of medical and technological documents on the 
basis of evidence. Methods: Evidence of clinical effectiveness is the main crite-
rion in choosing the treatment methods combating tuberculosis. Results: Ukraine 
has recently introduced the methodology of developing unified clinical protocols 
of medical care based on adapted clinical guidelines, which in turn are the result 
of adaptation of the best international practice. In particular, within the project of 
combating TB the adapted clinical guidelines was developed based on the documents 
of NICE and WHO. In developing the protocol there identified found differences in 
the tuberculosis treatment in Ukraine compared to the best practice, which resulted 
in amendments to the corresponding regulations in health care. ConClusions: 
Practical recommendations derived from the evidence-based medicine allowed the 
change of approaches to diagnosis and treatment of tuberculosis in Ukrainian regu-
lations. 3-time examination by sputum smear and culture microscopy is replaced 
by 2-time, the duration of the basic course of chemotherapy is reduced from 8 to 6 
months and its intensity is reduced from 5-component to 4-component treatment for 
the treatment of new and recurrent cases of tuberculosis with sensitive mycobacteria. 
In order to integrate these changes into clinical practice local protocols and critical 
pathways for management of tuberculosis are developing in all health care facilities 
taking into account peculiarities of the region and available resources of the hospitals.
ReSPiRatoRy-Related diSoRdeRS – clinical outcomes Studies
PRS1
cHaRacteRiSticS of PatientS witH cHRonic obStRuctiVe PulmonaRy 
diSeaSe (coPd) ReceiVing inHaled coRticoSteRoid/long-acting  
b2-SS2-agoniSt (icS/laba) fixed combination PRoductS in engliSH 
PRimaRy caRe
Blak B.T., Rigney U., Emmas C., Hamblin A.
AstraZeneca UK Ltd., Luton, UK
objeCtives: ICS/LABA fixed combinations are used in patients with COPD with 
a history of repeated exacerbations i.e. worsening of disease including infections 
and who have significant symptoms despite regular bronchodilator therapy. This 
study describes the characteristics of COPD patients initiating ICS/LABA in English 
primary care. Methods: Patients with first prescription (index date) of flutica-
sone/salmeterol (FP/SM) or budesonide/formoterol (BUD/FM) between 01.01.2005-
31.10.2011 and a prior COPD record were selected from CPRD primary care records 
linked to Hospital Episode Statistics. Baseline characteristics prior to first ICS/LABA 
prescription were described as proportions, means and rates (95%CI). Prior exac-
erbations were defined as: antibiotic or oral corticosteroid prescriptions or COPD 
hospitalisation; multiple events within 14 days were treated as one event. Results: 
26,875 patients age≥ 40 at index were included with 75.9% initiating FP/SM and 
24.1% BUD/FM; mean age 70.3(70.1-70.4) and 69.0(68.8-69.3) years, respectively. In 
both cohorts 54% were male, approximately 36% current smokers, and 56% past 
smokers. Pneumonia within 1-year prior to index was slightly higher in FP/SM 
patients (1.9%(1.9-1.9)) compared to 1.4%(1.4-1.4) in BUD/FM), as was prior mean 
annual COPD hospitalisation rate (0.17(95%CI:0.16-0.17); 0.11(95%CI:0.10-0.12)). 
Amongst FP/SM patients 12.7%(95%CI:12.6-12.9) had COPD hospitalisations 1-year 
prior with 9.2%(95%CI:8.9-9.4) amongst BUD/FM. 37.2%(95%CI:36.7-37.7) of FP/SM 
patients received tiotropium 1-year prior with 35.4%(95%CI:34.5-36.2) amongst BUD/
FM. The majority of patients had received short-acting ß2-agonist; FP/SM patients: 
89.8%(95%CI:88.6-91.1), BUD/FM patients: 84.8%(95%CI :82.7-86.8). Proportions 
receiving inhaled-corticosteroids within 1-year prior was 50.9%(95%CI:50.3-51.6) and 
48.0(95%CI:46.8-49.2) for FP/SM and BUD/FM, respectively, oral-steroids figures were 
42.2%(95%CI:41.7-42.8) and 39.8%(95%CI:38.8-40.8), respectively, and mean annual 
exacerbation rate was 2.15(95%CI :2.12-2.18) and 2.02(95%CI:1.96-2.07), respectively, 
with 75.3%(95%CI:74.2-76.3) and 73.9%(95%CI:72.1-75.7), respectively, having exac-
erbations. ConClusions: Both groups had similar burden of COPD disease prior 
to starting fixed combination. The crude prevalences for some baseline character-
istics were slightly higher in FP/SM vs. BUD/FM highlighting the need for rigorous 
propensity score matching in any comparative outcomes research.
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objeCtives: Chronic Obstructive Pulmonary Disease (COPD) associated with heart 
disease is common; this fact leads to increase the number of postoperative compli-
cations. The aim of this study was to evaluate the benefits of preoperative physi-
otherapy (PT) among patients with COPD. Methods: Thirty-seven patients with 
COPD were included in the study those who underwent open heart surgery. Group1 
(n= 17) participated in pre- and postoperative PT while Group2 (n= 20) received only 
postoperative PT. Inclusion criteria: open heart surgery and patients diagnosed 
with COPD or have FEV1< 80%. Spirometric measurements (vital capacity= VC, 
forced expiratory volume= FEV1, maximum expiratory pressure= PEF) performed 
preoperatively and on the 3rd and 7thpostoperative days. Operative data, duration of 
mechanical ventilation, average stay of intensive care unit, incidence of atelectasis 
were also assessed. IBM SPSS Statistics 20 software was used for statistical analysis; 
t-test and Pearson-correlation was applied (p< 0.05). Results: VC, FEV1, PEF showed 
significantly decrease in Group1 (21.29±13.40%; 19.71±17.96%; 4.18±20.09%) com-
pared to Group2 (34.70±17.54%; 32.85±11.95%; 24.65±21.65%), (p1= 0.013, p2= 0.011, 
